ATLASMira Pharmaceuticals (MIRA) earnings date: Nov 12, 2026
Mira Pharmaceuticals (MIRA) reports earnings for the quarter ended Sep 30, 2026 on Thu, Nov 12, 2026.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on MIRA
| Last price | $0.57 (+4.0%) |
|---|---|
| Normal 1-day range (±1σ) | ±5.1% |
| Earnings beat history | Beat the EPS estimate in 3 of the last 5 reports |
These figures come from the same calibrated model and valuation as the Mira Pharmaceuticals stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Mira Pharmaceuticals reports on Nov 12, 2026. One email the day before, with ATLAS’s read on Mira Pharmaceuticals. You can switch it off at any time.
Alert me before MIRA reportsFree to start. Creating an account takes under a minute.
Notify me when Mira Pharmaceuticals reports
Track MIRA free Add Mira Pharmaceuticals to a free ATLAS watchlist and see its next report date in one place.
MIRA earnings at a glance
| Next report (confirmed) | Thu, Nov 12, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Sep 30, 2026 |
| Last report | Jul 22, 2026 · In line |
| Beat rate (last 5 reports) | 3 of 5 (60%) |
| Average EPS surprise | -4.1% |
| Average move around a report | ±3.9% (last 5) |
| Sector | Healthcare · Drug Manufacturers - General |
Mira Pharmaceuticals earnings history: last 5 reports
Mira Pharmaceuticals last reported on Jul 22, 2026: EPS of $0.07 against an estimate of $0.07 (0.0% surprise), in line with the estimate.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Jul 22, 2026 | $0.07 | $0.07 | 0.0% | In line | +1.2% |
| May 28, 2026 | $1.23 | $1.28 | +4.1% | Beat | -8.2% |
| Jan 16, 2026 | $4.47 | $4.67 | +4.5% | Beat | -0.7% |
| Nov 21, 2025 | -$0.29 | -$0.41 | -41.4% | Miss | +5.9% |
| Nov 13, 2025 | -$0.08 | -$0.07 | +12.5% | Beat | -3.5% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for MIRA
See the fair value, the probability range and the earnings history of Mira Pharmaceuticals on its ATLAS page.
Mira Pharmaceuticals (MIRA) stock analysisPlans from €3.99 a month.
Mira Pharmaceuticals earnings: frequently asked questions
When does Mira Pharmaceuticals (MIRA) report earnings?
Mira Pharmaceuticals is scheduled to report on Thursday, November 12, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
How often does MIRA beat earnings estimates?
Of its last 5 reports with a recorded result, Mira Pharmaceuticals beat the EPS estimate 3 times; the average surprise was -4.1%. Past results do not predict the next one.
How much does MIRA move around earnings?
Over its last 5 reports the stock moved an average of 3.9% (absolute, from the close before the report day to the close after it), and finished higher 2 of 5 times.
Did Mira Pharmaceuticals beat earnings estimates last quarter?
Mira Pharmaceuticals last reported on Jul 22, 2026: EPS of $0.07 against an estimate of $0.07 (0.0% surprise), in line with the estimate.
How much does MIRA usually move in a day?
On a normal trading day the ATLAS model puts MIRA’s one-day range at about ±5.1%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Thu, Nov 12, 2026
Educational information, not investment advice. Disclaimer